LH analog and dietary isoflavones support ovarian granulosa cell tumor development in a spontaneous mouse model.
The reproductive hormone environment is an important influence upon spontaneous ovarian granulosa cell (GC) tumor development in genetically susceptible (SWR x SWXJ-9) F1 female mice: androgenic support during puberty stimulates tumorigenesis, while exposure to 17beta-estradiol (E(2)) suppresses tumor initiation. We sought to determine whether gonadotropic stimulation was sufficient to initiate GC tumors in a grafted model system, and to determine the potential for dietary isoflavones (genistein and daidzein) as alternatives to E(2) for tumor chemoprevention in vivo. Isolated ovaries from pre-pubertal (SWR x SWXJ-9) F1 females were transferred to the kidney capsule of host mice homozygous for the hypogonadal (hpg/hpg) and severe combined immunodeficiency (scid/scid) mutations. CB17; HPG-Prkdc(scid) Gnrh1(hpg)/Bm host mice received either follicle-stimulating hormone (FSH), or a functional analog for LH human chorionic gonadotropin for 2 consecutive weeks, at which time the ovary grafts were examined for evidence of tumor initiation. LH analog administration, but not FSH, initiated GC tumorigenesis in the graft system, suggesting that the LH surge at puberty initiates GC tumor development in genetically susceptible female mice. To assess the chemopreventive potential of phytoestrogens, GC tumor frequency was compared between (SWR x SWXJ-9) F1 females reared on an isoflavone-free diet versus a diet supplemented with 125 mug/g each of the isoflavones daidzein and genistein. It was observed that (SWR x SWXJ-9) F1 females reared on isoflavone-supplemented diet maintained significantly higher GC tumor frequency (22%) than females reared on isoflavone-free diet (11%), and that non-tumor-bearing siblings reared on the isoflavones had significantly increased ovarian weight, indicative of an overall stimulation of the reproductive hormone axis. The stimulation of GC tumorigenesis by isoflavones, which contrasts with the chemopreventive action of E(2) (2.5 mg/kg) administration during pubertal maturation, may result from general stimulation of ovarian growth, and the inability of the genistein and daidzein supplements to suppress LH secretion.
Dorward
Ann M
AM
The Jackson Laboratory, 600 Main St., Bar Harbor, Maine 04609, USA. ann.dorward@jax.org
Shultz
Kathryn L
KL
Beamer
Wesley G
WG
D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced* / Q000187:drug effects; D006063:Chorionic Gonadotropin / Q000008:administration & dosage / Q000633:toxicity*; D004032:Diet; D004195:Disease Models, Animal; D004958:Estradiol / Q000008:administration & dosage; D005260:Female; D005640:Follicle Stimulating Hormone / Q000008:administration & dosage; D019833:Genistein / Q000008:administration & dosage / Q000633:toxicity; D006106:Granulosa Cell Tumor / Q000139:chemically induced* / Q000473:pathology / Q000517:prevention & control; D007529:Isoflavones / Q000008:administration & dosage / Q000633:toxicity*; D051379:Mice; D008817:Mice, Mutant Strains; D010051:Ovarian Neoplasms / Q000139:chemically induced* / Q000473:pathology / Q000517:prevention & control
D006063:Chorionic Gonadotropin; D007529:Isoflavones; D004958:Estradiol; C004742:daidzein; D005640:Follicle Stimulating Hormone; D019833:Genistein